Daptomycin 350 MG Injection — RxCUI 1996246
RxNorm drug concept · Semantic clinical drug
RxCUI 1996246
Semantic clinical drug · SCD
● Current RxNorm concept 19 FDA products
25 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1996246
Official nameDaptomycin 350 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped19
Package NDCs mapped25
Reported Medicaid activity (SDUD)29,287 prescriptions · 47 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Daptomycin Injection: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Daptomycin only comes as an intravenous (IV) medication — there is no pill form. It needs to go directly into your bloodstream to reach the serious infection it's treating, like a...
- Why am I getting daptomycin by IV instead of a pill?
- It depends on what's being treated. For complicated skin infections, treatment usually lasts 7 to 14 days. For a bloodstream infection, it can be 2 to 6 weeks. Your doctor will dec...
- How long will I need to be on this antibiotic?
🕸️ Concept Web — How Daptomycin 350 MG Injection Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Daptomycin 350 MG Injection
RxCUI 1996246 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Daptomycin
22299IN
-
Daptomycin
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Daptomycin Injection
1731096SCDF -
Daptomycin Injectable Product
1152143SCDG -
Injection
1649574DF -
Injectable Product
1151126DFG
-
Daptomycin Injection
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Daptomycin 350 MG
1996245SCDC
-
Daptomycin 350 MG
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Daptomycin 350 MG
SCDC · 1996245 -
Daptomycin Injection
SCDF · 1731096 -
Daptomycin Injectable Product
SCDG · 1152143
📦 FDA Products & Package NDCs
19 products · 25 package NDCs
25 package NDCs map to RxCUI 1996246 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00143-9445-01 | 1 VIAL, SINGLE-USE in 1 CARTON (0143-9445-01) / 10 mL in 1... | Daptomycin | Hikma Pharmaceuticals USA Inc. | 2025-12-11 |
| 00143-9455-01 | 1 VIAL, SINGLE-USE in 1 CARTON (0143-9455-01) / 7 mL in 1 V... | Daptomycin | Hikma Pharmaceuticals USA Inc. | 2026-02-25 |
| 00143-9456-01 | 1 VIAL, SINGLE-USE in 1 CARTON (0143-9456-01) / 7 mL in 1 V... | Daptomycin | Hikma Pharmaceuticals USA Inc. | 2025-12-11 |
| 00409-0120-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0120-01) / 7 mL in 1... | Daptomycin | Hospira, Inc. | 2021-08-02 |
| 00409-0122-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0409-0122-01) / 10 mL in 1... | Daptomycin | Hospira, Inc. | 2021-08-02 |
| 16729-0434-05 | 1 VIAL in 1 CARTON (16729-434-05) / 7 mL in 1 VIAL | Daptomycin | Accord Healthcare, Inc. | 2019-07-16 |
| 16729-0434-45 | 10 VIAL in 1 CARTON (16729-434-45) / 7 mL in 1 VIAL | Daptomycin | Accord Healthcare, Inc. | 2020-02-27 |
| 25021-0179-15 | 1 VIAL in 1 CARTON (25021-179-15) / 7 mL in 1 VIAL | Daptomycin | Sagent Pharmaceuticals | 2018-01-15 |
| 25021-0179-16 | 10 VIAL in 1 CARTON (25021-179-16) / 7 mL in 1 VIAL | Daptomycin | Sagent Pharmaceuticals | 2018-01-15 |
| 25021-0179-66 | 1 VIAL in 1 CARTON (25021-179-66) / 7 mL in 1 VIAL | Daptomycin | Sagent Pharmaceuticals | 2020-02-01 |
| 25021-0179-67 | 10 VIAL in 1 CARTON (25021-179-67) / 7 mL in 1 VIAL | Daptomycin | Sagent Pharmaceuticals | 2020-02-01 |
| 31722-0215-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (31722-215-01) / 7 mL in 1... | Daptomycin | Camber Pharmaceuticals, Inc. | 2022-12-23 |
| 31722-0215-10 | 10 VIAL, SINGLE-DOSE in 1 CARTON (31722-215-10) / 7 mL in 1... | Daptomycin | Camber Pharmaceuticals, Inc. | 2022-12-23 |
| 43598-0476-11 | 1 VIAL, SINGLE-DOSE in 1 CARTON (43598-476-11) / 7 mL in 1... | Daptomycin | Dr. Reddy's Laboratories Inc., | 2021-10-04 |
| 43598-0476-58 | 10 VIAL, SINGLE-DOSE in 1 CARTON (43598-476-58) / 7 mL in 1... | Daptomycin | Dr. Reddy's Laboratories Inc., | 2021-10-04 |
| 70511-0182-84 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70511-182-84) / 1 INJECTI... | Daptomycin | MAIA Pharmaceuticals, Inc. | 2025-09-08 |
| 70594-0053-01 | 1 VIAL, SINGLE-USE in 1 CARTON (70594-053-01) / 7 mL in 1 V... | Daptomycin | Xellia Pharmaceuticals USA LLC | 2019-03-15 |
| 70594-0060-01 | 1 VIAL, SINGLE-USE in 1 CARTON (70594-060-01) / 10 mL in 1... | Daptomycin | Xellia Pharmaceuticals USA LLC | 2023-11-03 |
| 70594-0066-01 | 1 VIAL, SINGLE-USE in 1 CARTON (70594-066-01) / 7 mL in 1 V... | Daptomycin | Xellia Pharmaceuticals USA LLC | 2023-11-03 |
| 71288-0017-15 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-017-15) / 7 mL in 1... | DAPTOMYCIN | Meitheal Pharmaceuticals Inc. | 2021-06-29 |
| 71288-0017-91 | 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-017-91) / 7 mL in 1... | DAPTOMYCIN | Meitheal Pharmaceuticals Inc. | 2022-04-05 |
| 71839-0108-01 | 1 VIAL in 1 CARTON (71839-108-01) / 7 mL in 1 VIAL | daptomycin | BE Pharmaceuticals Inc. | 2020-08-20 |
| 71839-0108-10 | 10 VIAL in 1 CARTON (71839-108-10) / 7 mL in 1 VIAL | daptomycin | BE Pharmaceuticals Inc. | 2020-08-20 |
| 72572-0100-01 | 1 VIAL, SINGLE-USE in 1 CARTON (72572-100-01) / 7 mL in 1 V... | Daptomycin | Civica, Inc. | 2019-09-03 |
| 72603-0147-01 | 1 VIAL, SINGLE-DOSE in 1 CARTON (72603-147-01) / 7 mL in 1... | Daptomycin | NorthStar RxLLC | 2023-04-18 |
Observed labelers:
Sagent Pharmaceuticals (4) ·
Hikma Pharmaceuticals USA Inc. (3) ·
Xellia Pharmaceuticals USA LLC (3) ·
Accord Healthcare, Inc. (2) ·
BE Pharmaceuticals Inc. (2) ·
Camber Pharmaceuticals, Inc. (2)
· +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🧾 Billing Codes (HCPCS)
Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
| Code | Descriptor | Mapped packages | Sources |
|---|---|---|---|
| J0878 | Daptomycin injection | 11 | CMS |
| J0873 | Inj daptomycin (xellia) | 3 | CMS |
| J0877 | Inj, daptomycin (hospira) | 3 | CMS |
| J0872 | Daptomycin (xellia) unrefrig | 2 | CMS |
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.